VF
DCOY

Virtu Financial’s Decoy Therapeutics DCOY Stock Holding History

Virtu Financial’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2
Closed -$17K – 2197
2022
Q2 		$17K Buy
2
+1
+100% +$8.63K ﹤0.01% 1363
2022
Q1 		$16K Buy
+1
New +$15.8K ﹤0.01% 1326
2021
Q4 		– Sell
-1
Closed -$30K – 2135
2021
Q3 		$30K Buy
+1
New +$34.5K ﹤0.01% 1348
2021
Q2 		– Hold
0
– -$20K – 2028
2021
Q1 		– Hold
0
– – – 1510
2019
Q2 		– Hold
0
– -$52K – 1822
2019
Q1 		– Hold
0
– – – 1211
2018
Q4 		– Hold
0
– – – 1414
2018
Q3 		– Hold
0
– – – 1360
2018
Q2 		– Hold
0
– -$109K – 2457
2018
Q1 		– Hold
0
– – – 1560

Other funds holding DCOY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
XSC
X-Square Capital Guaynabo, Puerto Rico $394M AUM 44.75% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
LNWWM
Laird Norton Wetherby Wealth Management San Francisco, California $2.45B AUM

Virtu Financial's DCOY Position: Q3 2022 in Review

Virtu Financial sold out of Decoy Therapeutics (DCOY) in Q3 2022, closing a stake of 2 shares — an estimated $17K sold.

Virtu Financial first reported a position in DCOY in Q3 2021 and held it in 3 quarters. The position peaked at $30K in Q3 2021. 16 funds tracked by Wall St. Rank hold DCOY as of Q3 2022.

  • Virtu Financial reported no remaining Decoy Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Virtu Financial sold 2 Decoy Therapeutics shares in Q3 2022, an estimated $17K.
  • Virtu Financial first reported a position in Decoy Therapeutics in Q3 2021 and held it in 3 quarters.
  • Virtu Financial's Decoy Therapeutics position peaked at $30K in Q3 2021.
  • 16 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q3 2022.

Based on Virtu Financial's 13F filing for Q3 2022, filed 7 Nov 2022.